New Key Statistics Module, Z-Score and F-Score
NAS:CRDF Key Ratios
| Market Cap $ M | 170.37 |
| Enterprise Value $ M | 116.32 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.18 |
| Price/Sales | 246.61 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.91 |
| Beneish M-Score | -1.97 |
| 10-y EBITDA Growth Rate % | 42.80 |
| 5-y EBITDA Growth Rate % | 30.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.61 |
| EV-to-EBITDA | -2.63 |
| PEG | -- |
| Shares Outstanding M | 46.55 |
| Net Margin (%) | -6,143.91 |
| Operating Margin % | -6,711.28 |
| Pre-tax Margin (%) | -6,143.91 |
| Quick Ratio | 4.97 |
| Current Ratio | 4.97 |
| ROA % (ttm) | -50.11 |
| ROE % (ttm) | -58.80 |
| ROIC % (ttm) | -633.95 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.12 |
CRDF Number of Guru Trades
CRDF Volume of Guru Trades
Gurus Latest Trades with NAS:CRDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRDF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cardiff Oncology Inc Insider Transactions
No Available Data
News about NAS:CRDF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers